Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

FRA/OFK0 stock hub

FRA/OFK0 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/OFK0is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

9.7B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/OFK0

In the news

Latest news · FRA/OFK0

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E15.9

P25 n/aP50 n/aP75 n/a

Trailing P/E18.2

P25 n/aP50 n/aP75 n/a

ROE48.4

P25 n/aP50 n/aP75 n/a

ROIC39.7

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/OFK0 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

212

Groups with data

Currency

EUR

Showing 212 of 212 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Finland
Country code	DE
Employees	4,132
Employees Change	149%
Employees Change Percent	3.84
Enterprise value	EUR 9.8B
Exchange	Frankfurt Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	EUR 9.7B
Price	EUR 34.4
Price currency	EUR
Rev Per Employee	472,555.66x
Sic	2834
Symbol	fra/OFK0
Website	https://www.orionpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.48%
EV Earnings	18.48x
EV/EBIT	14.63x
EV/EBITDA	13.46x
EV/FCF	48.93x
EV/Sales	5.01x
FCF yield	2.07%
Forward P/E	15.87x
P/B ratio	8.6x
P/E ratio	18.24x
P/S ratio	4.94x
PE Ratio10 Y	22.42x
PE Ratio3 Y	22.5x
PE Ratio5 Y	23.19x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	34.25%
EBITDA Margin	36.91%
FCF margin	10.24%
Gross margin	64.8%
Gross Profit	EUR 1.3B
Gross Profit Growth	29.42%
Gross Profit Growth Q	25.87%
Gross Profit Growth3 Y	14.51%
Gross Profit Growth5 Y	15.17%
Net Income	EUR 529.4M
Net Income Growth	52.39%
Net Income Growth Q	47.47%
Net Income Growth3 Y	16.36%
Net Income Growth5 Y	20.07%
Pretax Margin	34.02%
Profit Margin	27.11%
Profit Per Employee	EUR 128,122
ROA	22.11
Roa5y	16.95
ROCE	52.22
ROE	48.36
Roe5y	34.21
ROIC	39.73
Roic5y	35.26

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	24.51%
Cagr3y	20.79%
Div CAGR3	23.62%
Div CAGR5	-0.38%
EPS Growth	52.06
EPS Growth Q	46.74
EPS Growth3 Y	16.29
EPS Growth5 Y	20.17
FCF Growth	-1.04%
FCF Growth Q	-67.5%
FCF Growth3 Y	-16.6%
FCF Growth5 Y	-4.43%
OCF Growth	5.98%
OCF Growth Q	-52.2%
OCF Growth10 Y	1.23%
OCF Growth3 Y	-11.96%
OCF Growth5 Y	-0.51%
Revenue Growth	22.92x
Revenue Growth Q	17.8x
Revenue Growth3 Y	13.15x
Revenue Growth5 Y	12.85x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 1.03
Assets	EUR 2.1B
Cash	EUR 199.3M
Current Assets	EUR 1.4B
Current Liabilities	EUR 798.6M
Debt	EUR 330.3M
Debt EBITDA	EUR 0.45
Debt Equity	EUR 0.29
Debt FCF	EUR 1.65
Equity	EUR 1.1B
Interest Coverage	77.76
Liabilities	EUR 956.7M
Long Term Assets	EUR 667.9M
Long Term Liabilities	EUR 158.1M
Net Cash	EUR -131M
Net Cash By Market Cap	EUR -1.36
Net Debt EBITDA	EUR 0.18
Net Debt Equity	EUR 0.12
Net Debt FCF	EUR 0.66
Tangible Book Value	EUR 933.1M
Tangible Book Value Per Share	EUR 6.62

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.77
Inventory Turnover	1.45
Net Working Capital	EUR 633M
Quick ratio	1.13
Working Capital	EUR 612.6M
Working Capital Turnover	EUR 2.77

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.1%
Dividend Growth	2.57%
Dividend Growth Years	0%
Dividend per share	EUR 0.44
Dividend Years	6
Dividend Yield	1.24%
Ex Div Date	2026-03-26
Last Dividend	EUR 0.23
Payout Frequency	Semi-Annual
Payout Ratio	43.65%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	24.49%
200-day SMA	33.38
3Y total return	76.24%
50-day SMA	34.66
50-day SMA vs 200-day SMA	50over200
All Time High	37.4
All Time High Change	-8.02%
All Time High Date	2026-02-12
All Time Low	15.2
All Time Low Change	126.32%
All Time Low Date	2024-04-19
ATR	0.65
Ch YTD	8.86
High	34.4
High52	37.4
High52 Date	2026-04-21
High52ch	-8.02%
Low	34.4
Low52	27.2
Low52 Date	2025-05-15
Low52ch	26.47%
Ma50ch	-0.74%
Price vs 200-day SMA	3.06%
RSI	47.41
RSI Monthly	64.15
RSI Weekly	53.03
Sharpe ratio	0.79x
Sortino ratio	1.26
Total Return	1.14%
Tr YTD	9.65
Tr1m	-3.37%
Tr3m	-3.76%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 668.7M
Operating Income Growth	40.28
Operating Income Growth Q	47.43
Operating Income Growth3 Y	16.51
Operating Income Growth5 Y	19.86
Operating margin	34.25

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	123,112,532%
Net Borrowing	-3,000,000
Shares Insiders	8.75%
Shares Institutions	38.68%
Shares Qo Q	-0.05%
Shares Yo Y	0.1%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 200M
Average Volume	0x
Bv Per Share	7.97
CAPEX	EUR -76.4M
Ch1m	-3.37
Ch1y	22.86
Ch3m	-4.44
Ch3y	68.63
Ch6m	20.28
Change	-2.27%
Change From Open	0
Close	35.2
Days Gap	-2.27
Depreciation Amortization	52,100,000
Earnings Date	2026-04-23
EBIT	EUR 668.7M
EBITDA	EUR 720.8M
EPS	EUR 3.76
F Score	6
FCF	EUR 200M
FCF EV Yield	2.04x
Financing CF	-234,000,000
Fiscal Year End	December
Founded	1,917
Goodwill	87,200,000
Graham Number	13.02784
Graham Upside	-62.13
Income Tax	EUR 134.9M
Investing CF	-102,600,000
Is Primary Listing	0
Last Earnings Date	2026-04-23
Last Report Date	2026-03-31
Lynch Fair Value	EUR 37.86
Lynch Upside	10.07
Ma150	33.21
Ma150ch	3.58%
Ma20	35.29
Ma20ch	-2.52%
Net CF	-60,100,000
Next Earnings Date	2026-07-17
Open	34.4
P FCF Ratio	48.27
P OCF Ratio	34.93
Payment Date	2026-04-17
Ppne	458,200,000
Price Date	2026-05-08
Price EBITDA	EUR 13.39
Ptbv Ratio	10.35
Relative Volume	2,000x
Revenue	1,952,600,000x
Tax By Revenue	6.91x
Tax Rate	20.31%
Tr6m	21.15%
Z Score	8.69

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

FRA/OFK0 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.2%

$0.44 annual per share

Payout ratio

+43.7%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-0.4%

0 consecutive years of growth

Total shareholder yield

+1.1%

Next ex-dividend date: 2026-03-26

Performance

FRA/OFK0 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/OFK0?

Insider, institutional, and short-interest positioning.

Institutional ownership

+38.7%

Share of float held by funds and institutions

Insider ownership

+8.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.1%

Negative means the company is buying back shares.

Technical

FRA/OFK0 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

47.4

Neutral momentum band

Price vs 200-day MA

+3.1%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.79

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/OFK0

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/OFK0 stock rating?

fra/OFK0 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/OFK0 analysis?

The full report lives at /stocks/fra/OFK0/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/OFK0?

The latest report frames fra/OFK0 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/OFK0 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.